Marker Therapeutics Inc (MRKR)

[rfj1862]

For everyone saying that the company mismanaged this, AgAiN, it wasn't on the company. It was on AACR.

Sorry I disagree. It is the company's obligation to understand when the data would be available to the public, and to do a contemporaneous press release, at a minimum. That's biotech 101.

They were clearly taken by surprise; the data is now out there with no context whatsoever.

PS: I think the data are spectacular. The way this trial has been handled from the beginning makes me think we have a junior varsity management team. If I were involved in this cluster-f I would be mortified.